SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-09-000004
Filing Date
2009-01-21
Accepted
2009-01-21 17:00:15
Documents
4
Period of Report
2009-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR PIPE OF JAN 2009 DOR pipe0120098k.htm 8-K 32899
2 SECURITIES PURCHASE AGREEMENT securitiespurchaseagreement.htm EX-10.1 190475
3 FORM OF WARRANT formofwarrant.htm EX-10.2 79346
4 REGISTRATION RIGHTS AGREEMENT registrationrightsagreement.htm EX-10.3 160785
  Complete submission text file 0000812796-09-000004.txt   465285
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09537099
SIC: 2834 Pharmaceutical Preparations